Copyright
©The Author(s) 2023.
World J Diabetes. Nov 15, 2023; 14(11): 1672-1692
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1672
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1672
Figure 5 Molecular docking.
A: Demonstration of docking outcomes between glycyrrhetinic acid (GA) components and core target molecules; B: Presentation of docking results and binding energies between GA components and core target molecules; C: Heat map display of molecular docking binding energy results. GA: Glycyrrhetinic acid.
- Citation: Meng FD, Yuan L, Xu DJ, Che MY, Hou SZ, Lu DD, Liu WJ, Nan Y. Exploring the targets and molecular mechanism of glycyrrhetinic acid against diabetic nephropathy based on network pharmacology and molecular docking. World J Diabetes 2023; 14(11): 1672-1692
- URL: https://www.wjgnet.com/1948-9358/full/v14/i11/1672.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i11.1672